This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
MM - 455
Multiple Myeloma (MM)
Abstract
Background
Multiple myeloma (MM) outcomes have improved over time; however, less is known about national trends in
nutritional decline near the end of life. We examined malnutrition, cachexia, weight loss, and dysphagia-associated
mortality among MM decedents and evaluated contemporary demographic and place-of-death patterns.
Methods
We used CDC WONDER Multiple Cause of Death data. Long-term trends were assessed using 1999–2020
bridged-race data, and contemporary patterns were evaluated using 2018–2024 single-race data. MM was
defined by ICD-10 code C90.0. Core nutritional vulnerability was defined as co-mention of protein-energy
malnutrition or cachexia (E40–E46 and R64). An expanded nutritional-frailty phenotype additionally included
abnormal weight loss and dysphagia (ICD-10: R63.4 and R13). We assessed mortality rates, the proportion of MM
deaths involving this phenotype, place of death, demographic/geographic patterns, and selected co-occurring
conditions.
Results
From 1999–2020, 294293 MM-associated deaths were identified. Overall MM age-adjusted mortality decreased
from 4.5051 to 3.8011 per 100000 (-15.6%). In contrast, expanded nutritional-frailty phenotype-associated MM
mortality increased from 0.0552 to 0.0891 per 100000 (+61.4%), and the proportion of MM deaths involving
this phenotype increased from 1.23% to 2.47%. Core malnutrition/cachexia-associated mortality increased from
0.0476 to 0.0657 per 100000 (+38.0%). This increase was primarily driven by malnutrition-associated mortality,
which rose from 0.0274 to 0.0597 per 100000 (+117.9%), whereas cachexia-associated mortality decreased.
In 2018–2024, 3282 of 106937 MM deaths involved the expanded phenotype (3.07%). Phenotype involvement
increased with age, from 2.07% among decedents aged 55–64 years to 3.63% among those aged ≥85 years,
and was highest among nursing home/long-term care deaths (4.83%). The West had the highest proportional
burden (3.90%), while the South had the largest absolute number of phenotype-associated deaths. In exploratory
analyses restricted to MM as the underlying cause, frequent co-occurring conditions included renal failure
(21.4%), anemia (19.8%), dysphagia (17.8%), pneumonia (10.8%), and sepsis (10.3%).
Conclusion
Despite declining overall MM mortality, mortality associated with nutritional decline increased substantially.
These findings suggest that malnutrition and related frailty markers remain underrecognized end-of-life burdens
in MM and may identify patients who could benefit from earlier supportive care assessment.
CDC WONDER: Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological
Research, ICD-10: International Classification of Diseases, 10th Revision, MM: multiple myeloma
Keywords
MM, multiple myeloma, nutritional vulnerability, malnutrition, end-of-life care, mortality disparities